BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank93
3Y CAGR+24.6%
5Y CAGR+50.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+24.6%/yr
vs +40.7%/yr prior
5Y CAGR
+50.8%/yr
Recent deceleration
Acceleration
-16.1pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
7.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $37.59M | -17.3% |
| 2024 | $45.43M | +45.4% |
| 2023 | $31.24M | +60.8% |
| 2022 | $19.42M | +118.7% |
| 2021 | $8.88M | +84.3% |
| 2020 | $4.82M | -22.7% |
| 2019 | $6.23M | +25.8% |
| 2018 | $4.96M | +54.1% |
| 2017 | $3.21M | +46.7% |
| 2016 | $2.19M | - |